Mark Matteucci

1.4k total citations
29 papers, 1.2k citations indexed

About

Mark Matteucci is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Mark Matteucci has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Organic Chemistry. Recurrent topics in Mark Matteucci's work include DNA and Nucleic Acid Chemistry (13 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Mark Matteucci is often cited by papers focused on DNA and Nucleic Acid Chemistry (13 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Mark Matteucci collaborates with scholars based in United States, China and France. Mark Matteucci's co-authors include Kuei‐Ying Lin, Robert J. Jones, Eric F. Fisher, Serge L. Beaucage, Jianxin Duan, Marvin H. Caruthers, Lincoln J. McBride, Anthony D. Barone, Peter G. Ng and Jin Tang and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Mark Matteucci

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Matteucci United States 17 909 254 170 103 68 29 1.2k
Francine E. Wincott United States 18 1.3k 1.4× 266 1.0× 114 0.7× 80 0.8× 43 0.6× 26 1.6k
Charles J. Guinosso United States 16 1.5k 1.7× 259 1.0× 116 0.7× 69 0.7× 73 1.1× 19 1.8k
Douglas S. Daniels United States 15 1.2k 1.3× 271 1.1× 115 0.7× 99 1.0× 20 0.3× 23 1.4k
E. Salah United Kingdom 19 1.0k 1.1× 172 0.7× 149 0.9× 239 2.3× 80 1.2× 47 1.4k
Alicia B Berger United States 8 633 0.7× 264 1.0× 107 0.6× 192 1.9× 26 0.4× 8 914
D. P. C. MCGEE United States 18 1.3k 1.4× 299 1.2× 130 0.8× 94 0.9× 146 2.1× 30 1.6k
Paul S. Miller United States 26 1.7k 1.8× 288 1.1× 147 0.9× 202 2.0× 92 1.4× 49 1.9k
Samu Melkko Switzerland 19 1.2k 1.4× 361 1.4× 141 0.8× 173 1.7× 15 0.2× 26 1.5k
Michael T. Migawa United States 25 2.0k 2.2× 465 1.8× 211 1.2× 63 0.6× 95 1.4× 50 2.5k
Noritaka Hashii Japan 22 1.2k 1.3× 219 0.9× 34 0.2× 93 0.9× 37 0.5× 69 1.4k

Countries citing papers authored by Mark Matteucci

Since Specialization
Citations

This map shows the geographic impact of Mark Matteucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Matteucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Matteucci more than expected).

Fields of papers citing papers by Mark Matteucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Matteucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Matteucci. The network helps show where Mark Matteucci may publish in the future.

Co-authorship network of co-authors of Mark Matteucci

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Matteucci. A scholar is included among the top collaborators of Mark Matteucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Matteucci. Mark Matteucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Donald, et al.. (2012). Metabolism and excretion of TH-302 in dogs. Xenobiotica. 42(7). 687–700. 2 indexed citations
2.
Duan, Jianxin, Xiaohong Cai, Fanying Meng, et al.. (2011). 14-Aminocamptothecins: Their Synthesis, Preclinical Activity, and Potential Use for Cancer Treatment. Journal of Medicinal Chemistry. 54(6). 1715–1723. 15 indexed citations
3.
Jung, Donald, et al.. (2011). Pharmacokinetics of TH-302: a hypoxically activated prodrug of bromo-isophosphoramide mustard in mice, rats, dogs and monkeys. Cancer Chemotherapy and Pharmacology. 69(3). 643–654. 15 indexed citations
4.
Jung, Donald, et al.. (2011). Metabolism, pharmacokinetics and excretion of a novel hypoxia activated cytotoxic prodrug, TH-302, in rats. Xenobiotica. 42(4). 372–388. 5 indexed citations
5.
Zhang, Jinsong, Jun Li, Dongming Chen, et al.. (2009). Inhibition of Both Thioredoxin Reductase and Glutathione Reductase may Contribute to the Anticancer Mechanism of TH-302. Biological Trace Element Research. 136(3). 294–301. 20 indexed citations
6.
Hart, Charles P., Fanying Meng, Monica Banica, et al.. (2008). In vitro activity profile of the novel hypoxia-activated cytotoxic prodrug TH-302. Cancer Research. 68. 1441–1441. 1 indexed citations
7.
Duan, Jianxin, Jacob A. Kaizerman, Timothy F. Stanton, et al.. (2008). Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs. Journal of Medicinal Chemistry. 51(8). 2412–2420. 188 indexed citations
8.
Meng, Fanying, Xiaohong Cai, Jianxin Duan, Mark Matteucci, & Charles P. Hart. (2007). A novel class of tubulin inhibitors that exhibit potent antiproliferation and in vitro vessel-disrupting activity. Cancer Chemotherapy and Pharmacology. 61(6). 953–963. 24 indexed citations
9.
Duan, Jianxin, Xiaohong Cai, Fanying Meng, et al.. (2007). Potent Antitubulin Tumor Cell Cytotoxins Based on 3-Aroyl Indazoles. Journal of Medicinal Chemistry. 50(5). 1001–1006. 46 indexed citations
10.
Meng, Fanying, et al.. (2007). ARC-111 inhibits hypoxia-mediated hypoxia-inducible factor-1α accumulation. Anti-Cancer Drugs. 18(4). 435–445. 10 indexed citations
11.
Matteucci, Mark. (2007). Oligoncleotide Analogues: An Overview. Novartis Foundation symposium. 209. 5–18. 5 indexed citations
12.
Matteucci, Mark. (1996). Structural modifications toward improved antisense oligonucleotides. Perspectives in Drug Discovery and Design. 4(1). 1–16. 27 indexed citations
13.
Lin, Kuei‐Ying, Robert J. Jones, & Mark Matteucci. (1995). Tricyclic 2'-Deoxycytidine Analogs: Syntheses and Incorporation into Oligodeoxynucleotides Which Have Enhanced Binding to Complementary RNA. Journal of the American Chemical Society. 117(13). 3873–3874. 128 indexed citations
14.
Lin, Kuei‐Ying & Mark Matteucci. (1991). Hybridization properties of deoxyoligonucleotides containing anthraquinone pseudonucleosides. Nucleic Acids Research. 19(11). 3111–3114. 16 indexed citations
15.
Matteucci, Mark, et al.. (1991). Deoxyoligonucleotides bearing neutral analogs of phosphodiester linkages recognize duplex DNA via triple-helix formation. Journal of the American Chemical Society. 113(20). 7767–7768. 40 indexed citations
16.
Froehler, Brian C., Peter G. Ng, & Mark Matteucci. (1988). Phosphoramidate analogues of DNA: synthesis and thermal stability of heteroduplexes. Nucleic Acids Research. 16(11). 4831–4839. 92 indexed citations
17.
Caruthers, Marvin H., Anthony D. Barone, Serge L. Beaucage, et al.. (1987). [15] Chemical synthesis of deoxyoligonucleotides by the phosphoramidite method. Methods in enzymology on CD-ROM/Methods in enzymology. 287–313. 275 indexed citations
18.
Hitzeman, Ronald A., Chung Nan Chang, Mark Matteucci, et al.. (1986). [60] Construction of expression vectors for secretion of human interferons by yeast. Methods in enzymology on CD-ROM/Methods in enzymology. 119. 424–433. 2 indexed citations
19.
20.
Caruthers, Marvin H., Serge L. Beaucage, Carol Becker, et al.. (1983). Deoxyoligonucleotide synthesis via the phosphoramidite method.. PubMed. 3. 1–26. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francine E. Wincott Breakdown of academic impact, for papers by Charles J. Guinosso Breakdown of academic impact, for papers by Douglas S. Daniels Breakdown of academic impact, for papers by E. Salah Breakdown of academic impact, for papers by Alicia B Berger Breakdown of academic impact, for papers by D. P. C. MCGEE Breakdown of academic impact, for papers by Paul S. Miller Breakdown of academic impact, for papers by Samu Melkko Breakdown of academic impact, for papers by Michael T. Migawa Breakdown of academic impact, for papers by Noritaka Hashii
Rankless by CCL
2026